Schedule 13G ownership disclosure
Context Therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 21077P108
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Martin Lehr
Shares: 1,595,742.00 · Class: 2.1%
- Martin Lehr 2000 Trust
Shares: 820,190.00 · Class: 1.1%
- Ellyn Lehr
Shares: 820,190.00 · Class: 1.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001842952-25-000014
- Form type
- SCHEDULE 13G/A
- Filer
- Context Therapeutics Inc.
- CIK
- CIK 1842952
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership